Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Letters
Accountability in Action: Repeal the Center for Medicare and Medicaid Innovation
Dear Representative/Senator, We appreciate your leadership in advancing President Trump’s agenda to reduce government spending and restore accountability by reining in bureaucracy and rooting out…
Blog
FDA’s Moderna decision demonstrates how science and government are incompatible
Last week, the FDA announced that it would not be considering Moderna’s application for a new flu vaccine because the control group Moderna used…
PCMA
No More Excuses After Pharma-Backed PBM Reform Becomes Law
Blog
Congress gets into the PBM business
In the recently passed appropriations bill, Congress enacted several Pharmacy Benefit Manager (PBM) reforms it has been contemplating for years. On the surface, these…
Op-Eds
Reform Obamacare, Don’t Just Extend It
Obamacare must be reformed, not just extended, as the House recently voted to do. Intended as a program to help people gain insurance coverage, it…